Ezaki Glico Co., Ltd. Logo

Ezaki Glico Co., Ltd.

2206.T

(2.2)
Stock Price

4.348,00 JPY

2.83% ROA

4.21% ROE

25.86x PER

Market Cap.

276.045.023.472,00 JPY

11.33% DER

1.84% Yield

3.3% NPM

Ezaki Glico Co., Ltd. Stock Analysis

Ezaki Glico Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Ezaki Glico Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (12%), which means it has a small amount of debt compared to the ownership it holds

2 Dividend

Investors can trust the company's impressive dividend track record, consistently distributing dividends over the past five years, showcasing a strong commitment to rewarding shareholders.

3 ROE

The stock's ROE falls within an average range (4.46%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (3.16%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 PBV

The stock's PBV ratio (1.01x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

6 Assets Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

7 Buffet Intrinsic Value

The company's stock presents an enticing opportunity as it appears undervalued (133.274) by Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

8 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

10 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

11 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

Ezaki Glico Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Ezaki Glico Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Ezaki Glico Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Ezaki Glico Co., Ltd. Revenue
Year Revenue Growth
2004 261.479.000.000
2005 260.991.000.000 -0.19%
2006 269.776.000.000 3.26%
2007 278.686.000.000 3.2%
2008 289.015.000.000 3.57%
2009 284.536.000.000 -1.57%
2010 284.048.000.000 -0.17%
2011 289.980.000.000 2.05%
2012 293.002.000.000 1.03%
2013 315.399.000.000 7.1%
2014 319.393.000.000 1.25%
2015 338.437.000.000 5.63%
2016 353.217.000.000 4.18%
2017 353.432.000.000 0.06%
2018 350.270.000.000 -0.9%
2020 344.048.000.000 -1.81%
2021 338.571.000.000 -1.62%
2022 303.921.000.000 -11.4%
2023 373.624.000.000 18.66%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Ezaki Glico Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Ezaki Glico Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 1.988.000.000
2005 1.533.000.000 -29.68%
2006 1.328.000.000 -15.44%
2007 1.066.000.000 -24.58%
2008 1.099.000.000 3%
2009 1.319.000.000 16.68%
2010 1.223.000.000 -7.85%
2011 1.523.000.000 19.7%
2012 26.261.000.000 94.2%
2013 0 0%
2014 27.912.000.000 100%
2015 29.983.000.000 6.91%
2016 30.398.000.000 1.37%
2017 29.965.000.000 -1.45%
2018 30.617.000.000 2.13%
2020 31.493.000.000 2.78%
2021 31.889.000.000 1.24%
2022 27.122.000.000 -17.58%
2023 28.756.000.000 5.68%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Ezaki Glico Co., Ltd. EBITDA
Year EBITDA Growth
2004 54.062.000.000
2005 55.157.000.000 1.99%
2006 56.031.000.000 1.56%
2007 53.875.000.000 -4%
2008 58.465.000.000 7.85%
2009 62.438.000.000 6.36%
2010 61.365.000.000 -1.75%
2011 57.894.000.000 -6%
2012 18.651.000.000 -210.41%
2013 25.378.000.000 26.51%
2014 29.216.000.000 13.14%
2015 30.627.000.000 4.61%
2016 37.954.000.000 19.3%
2017 36.432.000.000 -4.18%
2018 33.173.000.000 -9.82%
2020 35.259.000.000 5.92%
2021 36.345.000.000 2.99%
2022 28.436.000.000 -27.81%
2023 32.800.000.000 13.3%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Ezaki Glico Co., Ltd. Gross Profit
Year Gross Profit Growth
2004 112.769.000.000
2005 109.224.000.000 -3.25%
2006 112.874.000.000 3.23%
2007 113.489.000.000 0.54%
2008 118.765.000.000 4.44%
2009 123.791.000.000 4.06%
2010 123.902.000.000 0.09%
2011 123.316.000.000 -0.48%
2012 124.851.000.000 1.23%
2013 136.604.000.000 8.6%
2014 141.611.000.000 3.54%
2015 154.533.000.000 8.36%
2016 165.131.000.000 6.42%
2017 166.238.000.000 0.67%
2018 166.103.000.000 -0.08%
2020 162.408.000.000 -2.28%
2021 158.034.000.000 -2.77%
2022 110.749.000.000 -42.7%
2023 138.808.000.000 20.21%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Ezaki Glico Co., Ltd. Net Profit
Year Net Profit Growth
2004 3.449.000.000
2005 4.911.000.000 29.77%
2006 4.122.000.000 -19.14%
2007 1.406.000.000 -193.17%
2008 -1.067.000.000 231.77%
2009 7.031.000.000 115.18%
2010 3.785.000.000 -85.76%
2011 242.000.000 -1464.05%
2012 3.287.000.000 92.64%
2013 11.033.000.000 70.21%
2014 21.068.000.000 47.63%
2015 13.903.000.000 -51.54%
2016 18.147.000.000 23.39%
2017 15.216.000.000 -19.26%
2018 11.844.000.000 -28.47%
2020 11.836.000.000 -0.07%
2021 13.519.000.000 12.45%
2022 8.099.000.000 -66.92%
2023 20.700.000.000 60.87%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Ezaki Glico Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 52
2005 74 31.08%
2006 64 -17.46%
2007 22 -200%
2008 -17 223.53%
2009 124 113.82%
2010 67 -86.36%
2011 4 -1550%
2012 58 92.98%
2013 178 67.98%
2014 321 44.55%
2015 212 -51.42%
2016 276 23.19%
2017 231 -19.48%
2018 180 -28.33%
2020 182 1.1%
2021 208 12.5%
2022 127 -65.08%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Ezaki Glico Co., Ltd. Free Cashflow
Year Free Cashflow Growth
2004 5.853.000.000
2005 3.920.000.000 -49.31%
2006 7.570.000.000 48.22%
2007 -3.748.000.000 301.97%
2008 3.462.000.000 208.26%
2009 8.993.000.000 61.5%
2010 1.440.000.000 -524.51%
2011 -2.105.000.000 168.41%
2012 -564.000.000 -273.23%
2013 5.499.000.000 110.26%
2014 11.402.000.000 51.77%
2015 -2.794.000.000 508.09%
2016 9.290.000.000 130.08%
2017 11.916.000.000 22.04%
2018 1.847.000.000 -545.15%
2019 -3.067.000.000 160.22%
2020 474.000.000 747.05%
2021 4.887.000.000 90.3%
2022 -8.895.000.000 154.94%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Ezaki Glico Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
2004 15.876.000.000
2005 10.911.000.000 -45.5%
2006 15.469.000.000 29.47%
2007 6.724.000.000 -130.06%
2008 16.083.000.000 58.19%
2009 23.591.000.000 31.83%
2010 14.853.000.000 -58.83%
2011 10.236.000.000 -45.11%
2012 14.550.000.000 29.65%
2013 22.499.000.000 35.33%
2014 24.520.000.000 8.24%
2015 17.658.000.000 -38.86%
2016 29.563.000.000 40.27%
2017 31.493.000.000 6.13%
2018 20.324.000.000 -54.95%
2019 3.466.000.000 -486.38%
2020 17.218.000.000 79.87%
2021 28.651.000.000 39.9%
2022 16.802.000.000 -70.52%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Ezaki Glico Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
2004 10.023.000.000
2005 6.991.000.000 -43.37%
2006 7.899.000.000 11.5%
2007 10.472.000.000 24.57%
2008 12.621.000.000 17.03%
2009 14.598.000.000 13.54%
2010 13.413.000.000 -8.83%
2011 12.341.000.000 -8.69%
2012 15.114.000.000 18.35%
2013 17.000.000.000 11.09%
2014 13.118.000.000 -29.59%
2015 20.452.000.000 35.86%
2016 20.273.000.000 -0.88%
2017 19.577.000.000 -3.56%
2018 18.477.000.000 -5.95%
2019 6.533.000.000 -182.83%
2020 16.744.000.000 60.98%
2021 23.764.000.000 29.54%
2022 25.697.000.000 7.52%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Ezaki Glico Co., Ltd. Equity
Year Equity Growth
2004 115.931.000.000
2005 122.961.000.000 5.72%
2006 127.604.000.000 3.64%
2007 120.557.000.000 -5.85%
2008 98.400.000.000 -22.52%
2009 106.136.000.000 7.29%
2010 106.258.000.000 0.11%
2011 105.063.000.000 -1.14%
2012 114.295.000.000 8.08%
2013 141.439.000.000 19.19%
2014 169.311.000.000 16.46%
2015 173.591.000.000 2.47%
2016 192.449.000.000 9.8%
2017 214.786.000.000 10.4%
2018 220.852.000.000 2.75%
2020 222.549.000.000 0.76%
2021 241.176.000.000 7.72%
2022 244.758.000.000 1.46%
2023 265.405.000.000 7.78%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Ezaki Glico Co., Ltd. Assets
Year Assets Growth
2004 196.531.000.000
2005 212.730.000.000 7.61%
2006 211.671.000.000 -0.5%
2007 202.677.000.000 -4.44%
2008 193.051.000.000 -4.99%
2009 200.988.000.000 3.95%
2010 194.055.000.000 -3.57%
2011 207.292.000.000 6.39%
2012 219.361.000.000 5.5%
2013 243.241.000.000 9.82%
2014 275.301.000.000 11.65%
2015 274.974.000.000 -0.12%
2016 324.117.000.000 15.16%
2017 343.196.000.000 5.56%
2018 348.451.000.000 1.51%
2020 340.079.000.000 -2.46%
2021 356.744.000.000 4.67%
2022 369.054.000.000 3.34%
2023 401.785.000.000 8.15%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Ezaki Glico Co., Ltd. Liabilities
Year Liabilities Growth
2004 79.749.000.000
2005 88.772.000.000 10.16%
2006 84.067.000.000 -5.6%
2007 80.163.000.000 -4.87%
2008 92.944.000.000 13.75%
2009 92.701.000.000 -0.26%
2010 85.427.000.000 -8.51%
2011 99.938.000.000 14.52%
2012 103.016.000.000 2.99%
2013 97.740.000.000 -5.4%
2014 100.464.000.000 2.71%
2015 95.823.000.000 -4.84%
2016 125.684.000.000 23.76%
2017 128.410.000.000 2.12%
2018 127.599.000.000 -0.64%
2020 117.530.000.000 -8.57%
2021 115.568.000.000 -1.7%
2022 124.296.000.000 7.02%
2023 136.378.000.000 8.86%

Ezaki Glico Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
5092.94
Net Income per Share
167.89
Price to Earning Ratio
25.86x
Price To Sales Ratio
0.85x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
1.04
EV to Sales
0.64
EV Over EBITDA
10.54
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
0.04
FreeCashFlow Yield
0
Market Cap
276,05 Bil.
Enterprise Value
208,44 Bil.
Graham Number
3962.52
Graham NetNet
278.59

Income Statement Metrics

Net Income per Share
167.89
Income Quality
0
ROE
0.04
Return On Assets
0.03
Return On Capital Employed
0.06
Net Income per EBT
0.67
EBT Per Ebit
0.97
Ebit per Revenue
0.05
Effective Tax Rate
0.33

Margins

Sales, General, & Administrative to Revenue
0.08
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.37
Operating Profit Margin
0.05
Pretax Profit Margin
0.05
Net Profit Margin
0.03

Dividends

Dividend Yield
0.02
Dividend Yield %
1.84
Payout Ratio
0
Dividend Per Share
80

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.04
Return on Tangible Assets
0.03
Days Sales Outstanding
58.28
Days Payables Outstanding
75.12
Days of Inventory on Hand
62.76
Receivables Turnover
6.26
Payables Turnover
4.86
Inventory Turnover
5.82
Capex per Share
0

Balance Sheet

Cash per Share
1.531,84
Book Value per Share
4.156,63
Tangible Book Value per Share
3784.72
Shareholders Equity per Share
4156.63
Interest Debt per Share
472.39
Debt to Equity
0.11
Debt to Assets
0.07
Net Debt to EBITDA
-3.42
Current Ratio
1.63
Tangible Asset Value
241,17 Bil.
Net Current Asset Value
59,08 Bil.
Invested Capital
0.11
Working Capital
75,91 Bil.
Intangibles to Total Assets
0.06
Average Receivables
46,98 Bil.
Average Payables
37,61 Bil.
Average Inventory
36461500000
Debt to Market Cap
0.11

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Ezaki Glico Co., Ltd. Dividends
Year Dividends Growth
2001 10
2002 8 -42.86%
2003 10 30%
2004 10 0%
2005 10 0%
2006 10 0%
2007 15 33.33%
2008 15 0%
2009 15 0%
2010 15 0%
2011 15 0%
2012 15 0%
2013 15 0%
2014 15 0%
2015 50 70%
2016 40 -25%
2017 30 -33.33%
2018 55 45.45%
2019 95 42.11%
2020 65 -46.15%
2021 70 7.14%
2022 10 -600%
2023 40 75%

Ezaki Glico Co., Ltd. Profile

About Ezaki Glico Co., Ltd.

Ezaki Glico Co., Ltd., together with its subsidiaries, produces and sells confectionery and other food products in Japan, China, Southeast Asia, the United States, and internationally. The company operates through five segments: Confectioneries and Food Products, Ice Cream, Milk and Dairy, Food Ingredients, and Overseas. It produces and sells chocolates, cookies, curry roux, retort-packed food, and other products; milk and other dairy products, western-style fresh confectioneries, and baby formula products; snacks and ice creams; and starch, food coloring, and other products. The company also offers fruit juices and soft drinks, food and fine chemical materials, and health-related products. It sells its products in offices and stores, as well as through e-commerce. The company was founded in 1922 and is headquartered in Osaka, Japan.

CEO
Mr. Etsuro Ezaki
Employee
5.359
Address
6-5, Utajima, 4-chome
Osaka, 555-8502

Ezaki Glico Co., Ltd. Executives & BODs

Ezaki Glico Co., Ltd. Executives & BODs
# Name Age
1 Mr. Etsuro Ezaki
President, Senior Managing Executive Officer & Representative Director
70
2 Mr. Takashi Kuriki
Managing Executive Officer, Director of Biochemical Research Department & Director
70
3 Mr. Haruyoshi Kaneko
Director of Manufacturing Division of Production Dept and Director of Technical Development Dept
70
4 Mr. Yasuhito Murakami
Managing Executive Officer and Director of General Affairs & Human Resources Department
70
5 Mr. Shuji Fukagawa
Director of IR Dept, Director of Publicity & Director of Office Glico Promotion Dept
70

Ezaki Glico Co., Ltd. Competitors

Morinaga&Co., Ltd. Logo
Morinaga&Co., Ltd.

2201.T

(2.5)
Calbee, Inc. Logo
Calbee, Inc.

2229.T

(1.8)
Kewpie Corporation Logo
Kewpie Corporation

2809.T

(2.2)